For the Quarter Ending September 2025
North America
• In the USA, the Tetrasodium EDTA Price Index fell by 12.19% quarter-over-quarter, reflecting downstream demand.
• The average Tetrasodium EDTA price for the quarter was approximately USD 1530.00/MT, amid steady inventories.
• Tetrasodium EDTA Spot Price recovered in August as exporters adjusted offers while buyers remained selective.
• Tetrasodium EDTA Price Forecast suggests upward bias as importers replenish selectively ahead of Q4 production.
• Tetrasodium EDTA Production Cost Trend eased as formaldehyde feedstock softened, enabling exporters to lower offers.
• Tetrasodium EDTA Demand Outlook remains moderately mixed with personal care strength and restrained food sector replenishment.
• Tetrasodium EDTA Price Index showed volatility, export offer shifts and importer inventory adjustments influenced levels.
• Logistics stayed reliable at US ports though freight rate fluctuations added upward pressure on CFR.
Why did the price of Tetrasodium EDTA change in September 2025 in North America?
• Downstream inventory drawdowns in June reduced buffers, prompting urgent replenishment and temporarily firm import pricing.
• Declining formaldehyde feedstock costs lowered production expenses, allowing exporters to reduce offers and pressure prices.
• Efficient port operations avoided disruptions while variable freight rates added delivered cost volatility to CFR.
APAC
• In China, the Tetrasodium EDTA Price Index fell by 11.2% quarter-over-quarter, reflecting inventory overhang and subdued demand.
• The average Tetrasodium EDTA price for the quarter was approximately USD 1386.67/MT, supported by steady export flows.
• Tetrasodium EDTA Spot Price rose in August as urgent restocking addressed previously depleted downstream inventories.
• Tetrasodium EDTA Price Forecast projects gains into September, constrained by conservative procurement and balanced supply.
• Tetrasodium EDTA Production Cost Trend showed easing formaldehyde feedstock costs, allowing exporters to adjust offers.
• Tetrasodium EDTA Demand Outlook remains cautious; water treatment and personal care restocking offsets surplus inventories.
• Tetrasodium EDTA Price Index volatility reflects month-to-month inventory swings alongside stable logistics and buying cycles.
• Moderate inventories and smooth Qingdao logistics limited upside while steady export flows maintained supplier discipline.
• Major producers operated uninterrupted, supporting consistent shipments and reducing spot market urgency amid balanced dynamics.
Why did the price of Tetrasodium EDTA change in September 2025 in APAC?
• Renewed downstream restocking after low inventories drove upward pressure, especially from pharmaceutical and food formulation sectors.
• Lower formaldehyde feedstock costs eased production expense, enabling exporters to reduce offers and stimulate buyer interest.
• Efficient Qingdao logistics reduced delivery risks, maintaining steady export flows which tempered volatility and supported balanced pricing.
Europe
• In Germany, the Tetrasodium EDTA Price Index fell by 10.39% quarter-over-quarter, reflecting weaker export offers.
• The average Tetrasodium EDTA price for the quarter was approximately USD 1486.00/MT, based on Hamburg.
• Tetrasodium EDTA Spot Price firmed modestly in August as urgent replenishment reduced short-term availability pressures.
• Tetrasodium EDTA Production Cost Trend eased as formaldehyde feedstock prices declined, lowering exporter breakeven levels.
• Tetrasodium EDTA Demand Outlook remains stable across personal care, pharmaceuticals and water treatment sectors supporting.
• Tetrasodium EDTA Price Forecast indicates modest gains ahead as importers replenish inventories and monitor signals.
• Tetrasodium EDTA Price Index volatility was limited by Hamburg port operations and stable regional freight.
• Domestic inventories allowed German buyers to defer purchases, dampening spot activity despite import cost headwinds.
Why did the price of Tetrasodium EDTA change in September 2025 in Europe?
• Lower formaldehyde feedstock costs prompted exporters to reduce offers, directly lowering German landed import prices.
• Elevated carryover inventories and front-loaded purchases reduced urgency, softening procurement and limiting price declines domestically.
• Currency fluctuations versus dollar and inland logistics constrained transmission of exporter discounts to German buyers.
For the Quarter Ending June 2025
North America
• The Tetrasodium EDTA Spot Price in North America surged by 5.20% in June 2025, reaching USD 1802/MT CFR New York, as strong downstream demand from pharmaceutical formulations, cosmetics, and cleaning agents drove a spike in Q2 procurement.
• The Tetrasodium EDTA Price Forecast suggests a potential stabilization trend in Q3 2025, supported by inventory normalization, though sustained offtake from pharma and water treatment sectors could lend short-term upward pressure.
• Why did the price change in July 2025?
Prices in July 2025 showed a soft correction as restocking activity slowed and inventory levels recovered post-Q2. With stable freight conditions and no production bottlenecks, mild downward adjustments emerged.
• The Tetrasodium EDTA Production Cost Trend remained unaffected by cost-side fluctuations, with upstream feedstock availability and core manufacturing running without disruption across source markets.
• Market-wide Inventory Dynamics showed significant depletion among U.S. buyers during May, triggering import demand for pharma-grade lots and contributing to price elevation in June.
• The Tetrasodium EDTA Demand Outlook remained strong across Q2 in sectors such as shampoos, household cleaners, and pharmaceutical excipients, reinforcing consistent offtake.
• Freight and Logistics operations remained predictable across inland and port-side systems, with only marginal price firmness attributed to minor international freight rate adjustments.
• Supplier Reliability stayed intact through Q2, with leading export hubs maintaining shipment schedules; price pressures were therefore primarily demand-driven, not due to supply tightness.
Asia Pacific
• The Tetrasodium EDTA Spot Price in China recorded a minimal increase of 0.32% in June 2025, reaching USD 1555/MT FOB Qingdao, as price stability was sustained by consistent production output and evenly spread demand.
• The Tetrasodium EDTA Price Forecast for Q3 2025 indicates a modest upside potential only if speculative buying intensifies, with overall global inventories and export demand appearing balanced.
• Why did the price change in July 2025?
Prices in July 2025 remained stable to marginally firm, supported by steady overseas orders and uninterrupted production from key Chinese suppliers amid subdued restocking behaviour.
• The Tetrasodium EDTA Production Cost Trend remained neutral, with upstream availability and plant operations proceeding normally without cost-push disturbances.
• Inventory Status indicated moderate buildup during early Q2 cycles, enabling suppliers to fulfil July orders without urgency or volatility in pricing.
• The Tetrasodium EDTA Demand Outlook remained steady across personal care and cleaning industries, while pharmaceutical-grade requirements fluctuated based on staggered procurement cycles.
• Export Flow and Supply Chain Stability were ensured by well-functioning port infrastructure and absence of new policy hurdles, helping maintain outbound shipment volumes.
• Overseas Buying Patterns reflected disciplined procurement, as international buyers refrained from forward-stocking and preferred just-in-time purchasing strategies.
Europe
• The Tetrasodium EDTA Spot Price in Europe increased marginally by 0.91% in June 2025 to reach USD 1665/MT CFR Hamburg, supported by steady domestic consumption and consistent supply flow from Asia.
• The Tetrasodium EDTA Price Forecast remains moderately optimistic for Q3 2025, assuming continued demand from pharmaceutical and household segments, with possible uplift during seasonal stockpiling phases.
• Why did the price change in July 2025?
European prices in July 2025 remained flat to slightly firm as balanced inventories and smooth material inflow kept urgency low, dampening the need for sharp price revisions.
• The Tetrasodium EDTA Production Cost Trend remained stable as most European imports were contracted at consistent FOB values, with no major feedstock or cost-push triggers.
• Inventory Status in the region indicated sufficient carryovers from earlier Q2 months, which cushioned market pricing and prevented abrupt volatility by end-June.
• The Tetrasodium EDTA Demand Outlook showed resilience across excipient applications, emulsifiers in cosmetics, and water system treatments, in line with seasonal consumption trends.
• Logistics and Freight Operations moved smoothly throughout Q2 across German ports, allowing for uninterrupted deliveries and maintaining price stability.
• Supplier Responses from Asian origins remained cooperative and neutral in pricing behaviour, ruling out any disruptive hikes from upstream sources.
For the Quarter Ending March 2025
North America
The North American market for Tetrasodium EDTA experienced a slight decline of 6.92% during the first quarter of 2025. This trend can be attributed to a combination of factors. Demand from downstream sectors such as pharmaceuticals, nutraceuticals and personal care products remained relatively steady but not robust enough to drive significant price increases.
The seasonal transition from winter to spring also played a role, as this period often brings adjustments in demand and production cycles, leading to softer market activity. Additionally, the continued presence of tariff impositions affected procurement strategies which had an indirect effect on price levels. Suppliers maintained well-managed inventory levels to balance steady demand without creating unnecessary price fluctuations.
The subdued demand and cautious purchasing behaviour from key industries contributed to the overall price moderation observed during this quarter. Despite these dynamics, the market remained stable and resilient. In summary, the North American market for Tetrasodium EDTA showed a slight price decline in first quarter of 2025 shaped by seasonality, procurement strategies and demand patterns.
Asia Pacific
The Asia Pacific market for Tetrasodium EDTA saw a decline of 7.03% in the first quarter of 2025. This decrease in prices can be attributed to a combination of seasonal factors and moderate demand fluctuations from key downstream sectors such as pharmaceuticals, nutraceuticals and personal care. The seasonal transition during this period with the Chinese Lunar Year resulted in slower manufacturing and production cycles and impacting overall market dynamics in APAC region.
Demand in the region remained stable but was not strong enough to support significant price increases. The festive season also led to temporary slowdowns in production, affecting supply levels and overall market activity. Suppliers in the region adjusted their procurement strategies, maintaining inventory levels that aligned with the lower demand. While the logistics and supply chains remained efficient, the subdued demand from end-user industries put some downward pressure on prices.
Overall, the Asia Pacific market for Tetrasodium EDTA saw a moderate price decline in first quarter of 2025. The price trend was influenced by seasonal transitions, holiday effects and steady but cautious demand from downstream sectors.
Europe
In Europe, the Tetrasodium EDTA market saw a moderate decline of 4.97% during the first quarter of 2025. This price adjustment is largely attributed to a combination of subdued demand from downstream sectors like pharmaceuticals, personal care, and nutraceuticals. While the supply remained steady, there was a slight dip in production activity, which contributed to the softer price trend.
The seasonal transition during this period also influenced demand, which typically experiences a dip as production cycles adjust. However, suppliers in the region employed strategic procurement practices and maintained inventory levels to balance the market and avoid sharp price changes. Logistics continued to run smoothly, which helped minimize any disruptions to supply chains. Despite the weaker demand, the market remained stable, with minor price fluctuations reflecting the natural ebb and flow of supply and demand. Overall, the European Tetrasodium EDTA market showed moderate price softness in first quarter of 2025 driven by seasonal demand patterns, cautious purchasing and consistent supply conditions.
For the Quarter Ending December 2024
North America
The U.S. Tetrasodium EDTA market in Q4 2024 showed a consistent decline, driven by excess supply and lackluster demand across key sectors. In October, prices dropped due to oversupply, with some production facilities operating at reduced capacity while others returned to full output. Price cuts by manufacturers failed to stimulate demand as inventories continued to rise. External factors, including falling crude oil prices, hurricane disruptions, and port strikes, further weighed on the market. Improved logistics costs allowed producers to lower prices, but demand remained weak, particularly in the healthcare sector, with buyers adopting more cautious purchasing strategies.
In November, the market briefly rebounded due to rising import costs from China and concerns over potential U.S. tariffs. Port congestion and higher shipping expenses contributed to the price increase, though logistical inefficiencies persisted.
By December, prices fell once more, driven by weak demand from sectors like pharmaceuticals and oversupply exacerbated by competition from Chinese imports. The market ended the year with high inventories and slow trading, as suppliers focused on clearing excess stock.
APAC
In Q4 2024, China’s Tetrasodium EDTA market experienced consistent downward pressure, mainly due to an oversupply and weak demand. In October, prices dropped sharply as a result of increased production, lower import volumes, and improved logistics, which led to market saturation. Although demand remained steady, it was insufficient to keep pace with the supply, putting downward pressure on prices.
In November, a further decline occurred as suppliers reduced inventories ahead of the holiday season, driving down export prices. While demand remained stable, aggressive inventory clearing and limited downstream capacity hindered any price recovery. Geopolitical factors, including potential new tariffs, further strained the market. Suppliers resorted to aggressive price cuts to manage high stock levels, while currency manipulation by China added to the pricing volatility.
With buyers cautious and limiting purchases, the market became a buyers' market, and conditions were unfavorable for sellers. Overall, Q4 2024 was marked by persistent price pressures, with little relief expected unless demand improves or production is reduced.
Europe
In Q4 2024, Germany's Tetrasodium EDTA market has seen consistent price declines due to weak demand, excess supply, and lower production costs. Cautious buying behavior, driven by importers focusing on essential purchases and controlling inventory, has kept prices under pressure. A favorable euro exchange rate has further exacerbated the situation, making imports more attractive.
Demand from downstream industries remains low, and trading activity has been minimal, contributing to an overall negative market sentiment. This lack of demand and the presence of surplus stock have forced producers to reduce prices and offer discounts in an attempt to manage inventory levels. With producers focused on destocking, price reductions and promotional strategies have deepened the market’s downturn.
Despite favorable production conditions, the market remains oversupplied, and demand from various sectors has been weak. This trend of excess inventory, limited procurement, and weak demand is likely to persist, maintaining downward pressure on prices throughout the quarter.
